Quick Answer
Matinas BioPharma Holdings, Inc. reported Cash And Cash Equivalents At Carrying Value of $4.00 million for the year ending 2025.
- Matinas BioPharma Holdings, Inc. showed a decrease of -45.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Matinas BioPharma Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), Matinas BioPharma Holdings, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 842.4%.
- Historical annual values: Fiscal year 2025: $4.00 million | Fiscal year 2024: $7.28 million | Fiscal year 2023: $4.79 million | Fiscal year 2022: $6.83 million | Fiscal year 2021: $21.03 million | Fiscal year 2020: $12.43 million | Fiscal year 2019: $22.17 million | Fiscal year 2018: $12.45 million | Fiscal year 2017: $7.31 million | Fiscal year 2016: $4.11 million | Fiscal year 2015: $3.23 million | Fiscal year 2014: $2.59 million | Fiscal year 2013: $10.84 million | Fiscal year 2012: $424.4 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: